MASLD Is Associated With an Increased Long-Term Risk of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis.

导出 LinkOut

翻译打印收藏纠错

作者： Alessandro,Mantovani ^[1] ; Riccardo,Morandin ^[1] ; Elena,Sani ^[1] ; Veronica,Fiorio ^[1] ; Emigela,Shtembari ^[1] ; Stefano,Bonapace ^[2] ; Salvatore,Petta ^[3] ; Stergios A,Polyzos ^[4] ; Christopher D,Byrne ^[5] ; Giovanni,Targher ^[6]

作者单位： Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy. ^[1] Division of Cardiology, IRCCS Sacro Cuore-Don Calabria Hospital, Negrar di Valpolicella, Negrar, Italy. ^[2] Section of Gastroenterology and Hepatology, PROMISE, University of Palermo, Palermo, Italy. ^[3] First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. ^[4] National Institute for Health and Care Research, Southampton Biomedical Research Centre, University Hospital Southampton and University of Southampton, Southampton, UK. ^[5] Department of Medicine, University of Verona, Verona, Italy.;Metabolic Diseases Research Unit, IRCCS Sacro Cuore-Don Calabria Hospital, Negrar di Valpolicella, Negrar, Italy. ^[6]

关键词 MASLD NAFLD arrhythmias atrial fibrillation metabolic dysfunction‐associated steatotic liver disease non‐alcoholic fatty liver disease